Better Late Than Never: Can China Help Kenya Break The 2% Vaccine Wall?

 In 分析, op-ed

After walking out of the COVID-19 vaccination clinic in Nairobi, with my arm slightly sore after receiving my first free dose of the AstraZeneca vaccine, I felt hopeful that this reflected a new stage in Kenya’s COVID-19 response. However, a few weeks on, it has become clear that our vaccine rollout has not been smooth sailing, having only received enough doses to cover 1.6% of our population.

But before I delve into this, it is important to note Kenya’s achievements in its handling of COVID. After reporting its first COVID-19 case in March 2020, Kenya adopted rapid response measures, with the government implementing social distancing measures before recording over 50 cases. These measures have played a huge role in easing pressure on our healthcare infrastructure, and with only  156,787 cases and 2,622 deaths recorded, a significant achievement compared to South Africa with 1.58 million cases and 54,148 deaths.

International partners also provided support during the initial COVID-19 response, with the US government, for example, donating 200 ventilators. China was also among the first countries to lend support, with, for instance, the Jack Ma Foundation providing PPE donations, and the Zhejiang Business Association Kenya, an association of Chinese business owners in Kenya, donating 70,000 face masks.

But when it comes to vaccines – there has been a significant delay in vaccine procurement, with our government only very recently procuring vaccines from China in mid-May. So, what difference – if any at all – will this make to our rollout?

Currently, our government is still only using the Oxford-AstraZeneca vaccine, procured from COVAX and India. According to government estimates, by late April our vaccine resources were rapidly declining, with just over 1 million doses had been administered – and only 21,000 doses left in stock. The rollout had only just begun in March 2021, but as with many African countries, it has lagged behind the rest of the world. Indeed, only 1.42% of the continent’s population have received a vaccine dose so far – that’s less than 1 in 100 people. Comparatively, this figure stands at 32 in 100 people in North America, and 19 in 100 in Europe. This leaves African countries, including Kenya, to prolong protective measures which hinders economic recovery.

We are expected to receive a further 24 million AstraZeneca doses through COVAX, with another 10.8 million from the African Union and 12 million from bilateral agreements. Our government also recently ordered 30 million doses from Johnson and Johnson, which is being manufactured in South Africa, planned to be delivered within the year. Additional Pfizer and Johnson and Johnson are also planned to be procured through the African Union. In total, at least 30 million doses are needed to vaccinate 60% of our population, the minimum goal according to GAVI.

Clearly the global supply chain is not working. Despite these orders, we have only received enough doses to cover under 2% of our population, with only 1.12 million doses from COVAX, and 100,000 vaccine doses donations from India actually delivered. Kenya is not alone in this situation, as only three out of Africa’s 54 countries have received enough doses to cover over 10% of their population (Seychelles 76%, Djibouti 16% and Morocco 12%). Delays by the Serum Institute in India, which plan to reduce vaccine exports following a surge in infections domestically, also necessitates procurement from other sources.

Whilst the number of vaccines procured from China has not yet been made public, the procurement still comes at a crucial point in time, as our vaccine supplies become acutely exhausted. There had initially been plans to obtain doses from Chinese partners in December 2020, with our President directing the health ministry to explore ways of obtaining the Chinese vaccines. However, these plans were non-conclusive and efforts to procure Chinese-made vaccines fizzled away.

The turning point was unmistakably the approval of China’s Sinopharm vaccine by the WHO for emergency use, which likely boosted the confidence of our government regarding the safety and efficacy of Chinese-made vaccines. Additionally, the approval also significantly expands COVAX vaccine supply, which is crucial since China possesses extensive vaccine manufacturing capacity equating to around 5 billion doses per year. Sinovac is also set for WHO review in early May and if also approved, this would provide an additional impetus for our government to procure further doses from China.

As a Development Partner, There Are Numerous Additional Ways China Can Further Its Support to Kenya During This Critical Time.

One method is increasing the supply of vaccines and PPE. This, of course, involves our government making further commitments to vaccine procurement, with China being one potential source. Diversifying vaccines is becoming more critical as vaccine hesitancy is increasing following reports of blood clots linked to AstraZeneca, which is still the only vaccine available.

China would be an essential partner for bilateral procurement, especially considering its advantage in manufacturing capacity. For instance, China’s COVID-19 vaccine production capacity could total to 4 billion doses by the end of 2022 –covering around 40% of world demand. Further, the production capacity of PPE supplies has also been drastically scaled up, with China’s daily outputs of N95 masks jumping from 200,000 to 1.6 million. Chinese partners should look to subsidise the procurement of vaccines and PPE supplies, which would provide Kenya with additional fiscal space to finance economic recovery.

This suggestion is not farfetched, especially since China has provided vaccines through donations and commercial measures to numerous African countries, not all of which are classified as low income. For instance, Algeria and Egypt, received 200,000 and 300,000 doses of SinoPharm donations, respectively. Another example is Zimbabwe, which received 200,000 of its second batch of SinoPharm donations, with the Zimbabwean government taking active steps to procure an additional 1.2 million doses of Sinovac. These are steps we should also be taking.

Procurement of both vaccines and PPEs should be a priority, as our vaccination rate is highly unsustainable. Prolonged COVID-19 measures will continuously push our economic recovery further and further back, with the World Bank recently reporting that an extra two million Kenyans will be pushed into poverty due to COVID. We need to be taking further action now.

Looking longer-term, Chinese investors should support capacity building in Kenya’s local pharmaceutical manufacturing sector. Currently, Kenya cannot manufacture vaccines, yet, our government offers a plethora of incentives for pharmaceutical investment, including 100% foreign ownership, free allocation of land and/or plans for a pharmaceutical industrial park, and tax incentives. Perhaps most importantly, our government also offers guaranteed purchases from local manufacturers through The Kenya Medical Supplies Authority. Supporting the development of the Kenyan health sector will contribute towards Kenya’s development agenda, Vision 2030, which aims to establish a universal health care system by 2030.

Whilst China’s role in Kenya’s COVID-19 response has relatively delayed, there are still avenues where China can assist. I still hold hope that our vaccination rollout will speed up and that my inclusion in the ‘2%’ category will no longer be the case. But for this to be a reality, international actors – including China – must play their part.

Patrick Anam is International Trade Policy and Trade Law Expert at Development Reimagined and is based in Nairobi.

This article was originally published on The China-Africa Project on May 28th 


Recommended Posts

Leave a Comment

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

验证码不清楚,请更换一张 captcha txt


Research Analyst

Edmond is a research analyst who is passionate about sustainable development, innovation, and the environment. Passionate about climate financing, he firmly believe there is a more reliable system to promote equality, growth, and welfare in societies without affecting the ecosystem. Through his skills, knowledge and experienced gained over 7 years, he wants to make an impact in the world of development. Edmond holds a Master’s Degree in Public Policy from Korea Development Institute and a BA Degree (Honors) in Business from University of Derby.


    Founder and CEO

Hannah Ryder is the Founder & CEO of Development Reimagined. A former diplomat and economist with 20 years of experience, named one of 100 most influential Africans in 2021, she is also Senior Associate for the Africa Program of the Center for Strategic International Studies (CSIS), sits on the Board of the Environmental Defence Fund, and is a member of UAE's International Advisory Council on the New Economy. Prior to her role at DR, Ms Ryder led the United Nations Development Programme (UNDP)’s work with China to help it scale up and improve its cooperation with other developing countries, including in Africa. She has also played various advisory roles for the UN and OECD and co-authored the seminal Stern Review of the Economics of Climate Change in 2006.


Deputy Director

Leah Lynch is Deputy Director of Development Reimagined (DR), and head of the China office. Leah has over 10 years of experience in development and has lived in China for over 8 years. Leah has also travelled extensively around Asia and Africa for research. Leah supports the strategic direction of the team across China, with a mission to deliver high quality research on sustainable development and poverty reduction. Leah is also Chair of the Sustainability Forum at the British Chamber of Commerce in China, providing direction on sustainability initiatives for British and Chinese business. Leah has also consulted on various evaluations on UK aid (ICAI) and is a specialist on development cooperation from the UK and China. Leah has also consulted on various UN projects, including providing support to the UN China team during the COVID-19 Pandemic. Prior to DR, Leah was at the United Nations Development Programme (UNDP) China, supporting the UN’s portfolio on communication strategies, China’s South- South Cooperation and the Belt and Road Initiative (BRI). Before UNDP, Leah lived and worked in Kenya developing sustainable water policies for the Kenyan government.


China-Africa Policy Analyst

Yike Fu is a Policy Analyst and has been responsible for leading numerous areas of work, including on debt analysis in Africa and beyond, and China-Africa trade and investment logistics and analysis. She is the co-author of “African Debt Guide”, in which she challenged the narrative that Africa is in the midst of a new debt crisis by analysing data back to the 1970s and adopting new metrics to present the real story behind the data. She also developed a benchmark to compare the financial distribution of development partners such as the UK, US, Japan, France and China in Africa. Prior to her role at DR she worked at the International Finance Corporation and African Union Representational Mission to the US. She holds a Masters in International Affairs from George Washington University.


Research Analyst

Judith is a Research and Policy Analyst, where she specialises in Africa-China relations, international development, and diplomacy. During her time at Development Reimagined, Judith has co-authored several articles published in The Diplomat on debt and China-Barbados relations and was quoted by China Daily in a piece on Women Rights in China. Previously, Judith worked as a research analyst for an Advocate and Commissioner and Oats office in Kenya.


Policy Analyst

Ovigwe specialises in geopolitics with particular reference to Africa in a changing Global Order. He is adept at critically analysing the politics of contemporary development processes and providing insight into the geopolitical interests that influence them. His work includes research, publications, tailored briefings and advising on global and regional trends, and issues at the nexus of geopolitics and development. Ovigwe appears frequently in media around the world such as Al Jazeera, TRT World, SABC, CGTN, BBC Radio, and other platforms.


Policy Analyst

Jing leads China-African health and agriculture cooperation research at Development Reimagined, having managed our FOCAC Policy Analysis and Advocacy project. She is also the co-author of “China-Africa Health Cooperation under FOCAC Umbrella”, in which she analysed China’s commitments around health cooperation since the first FOCAC summit and deepdived into four African countries’ health overview, challenges and cooperation with China as cases studies. Before DR, Jing worked at GIZ Cambodia on M&E of a disability advocacy project. She also worked as a translator with Chinese medical team in Benin.


Trade Policy Analyst

Patrick is an International Trade Policy and Trade Law Expert with over 5 years of experience. His expertise includes trade law, trade policy analysis and regional integration. He is currently engaged with Development Reimagined as a Senior Trade Analyst and was the lead author of Development Reimagined's recent Report on Africa-China Relations titled "From China-Africa to Africa- China: A Blue Print for a Green and Inclusive Continent-Wide Strategy Towards China." and “Reimaging FOCAC Going Forward.” Patrick has previously consulted for the East African Community, UNECA and for the Kenya Ministry of Trade.


Senior Policy Analyst 

Rosemary is our Senior Policy Analyst. She is a skilled policy analyst and has previously worked as a UK civil servant. She is studying Human Rights at Birkbeck, University of London with a research focus on international law in the context of health crises such as the COVID-19 pandemic.


Project Manager and Africa-China Communication Assistant

Jade is a Project Manager for Development Reimagined’s flagship project Africa Unconstrained, which focuses on financing needs and debt vulnerabilities of African countries. Her research focuses on China-Africa development finance alongside debt vulnerabilities, infrastructure needs and South-South cooperation. She has worked with a breadth of stakeholders from China, Africa and the wider international community, including governments, private sector, NGOs and civil society. Her writing has appeared in a number of publications, including The Africa Report, The China-Africa Project, The Diplomat and more. Jade holds a Master’s in China and Globalisation studies from King’s College London.


Programme Manager

Rosie is the Project Manager of Africa Reimagined (AR) at Development Reimagined (DR) where she supports high-end African brands with entering the Chinese market by operating services such as trademark protection, Chinese market research, Chinese partnership building, and Africa to China logistical support and import/export services. Rosie has worked with DR for over two years now with proven success in helping high-end African brands navigate the Chinese market. She is extremely passionate about her work because more African brands selling in the Chinese marketplace means African countries can export MORE value-added goods, create MORE jobs and foster MORE innovation in African countries.

Rosie is also alumni of the School of International Studies at Peking University in Beijing where she is also an editor at the Peking Africa Think Tank. PATT is led by a diverse group of scholars who specialise in African Studies within the context of Sino-Africa relations.



Lauren has lived in six countries from the Americas to Europe and Asia and speaks both French and Spanish proficiently. At Development Reimagined, Lauren’s research focuses on climate action both in the Asia-Pacific and in Africa, and how countries are using tools such as SDGs and Covid-19 action to build a more climate-resilient future. She holds a Masters in International Relations from Leiden University.



Etsehiwot holds a Masters’s degree in Development Studies from the London School of Economics. She has diverse experience in humanitarian and development issues by working in both multilateral organizations and international non-governmental organizations. Etsehiwot is currently a consultant focusing on the SDGs and development finance.


Economist Consultant

Dibekulu is an economist by training. He holds an MSc in International Development Studies from Palacky University Olomouc, an MSc in Development Economics from the University of Clermont Auvergne, and an MSc in Economics, Finance, and International Integration from the University of Pavia. At Development Reimagined, he works as an Economist consultant. He has strong data analysis skills, with research interests centring around development finance, impact assessment, food security, and agricultural insurance.


Project Manager

Osaru is a health professional with an MSc in Health Systems Policy and an interest in women’s health and population management. At Development Reimagined, she applies her health sector experience to global health research and collating locally applicable development insights from China.


Research Analyst

Ferdinando’s research at Development Reimagined is centred on South-South Cooperation dynamics, specifically on the analysis of Chinese investment and debt flows in Africa and their linkages to African industrialisation. He is currently a Yenching Scholar at Peking University, after having graduated from the University of Cambridge with an MPhil in Development Studies.


Research Analyst

David is a Research and data analyst at Development Reimagined. His scholarly focus is mostly on interdisciplinary research in demographic economics and development with interests in migration, economic development and policy, education, health and subjective well-being. He is currently a PhD scholar at Nelson Mandela University from which he also holds Economics and Statistics and respectively.


Research Analyst Kenya

Ivory is a Kenyan lawyer with experience in policy research and analysis. She also supports the communications team at DR. Ivory speaks English, Swahili and French.


Research And Data Analyst China 

Joy Ene is a Research and Data Analyst at DR. Joy is passionate about African/global development, poverty eradication and trade policies between underdeveloped and developing countries. She is also a fourth-year student of International Economics and Trade at the  Liaoning University, Shenyang, China. She serves as the President of the Student Union, Liaoning University, International Students chapter.


Research Analyst 

Chensi Li is a research analyst. She has previously worked for local NGOs in Nigeria and Cameroon and think-tanks in China.  Her research areas include Sino-African relations, African foreign affairs, public diplomacy, state-building and national governance.

Yixin Yu

Research Analyst 

Yixin is a Junior Research Analyst and her focus areas is on public-private partnership and entrepreneurship. She has over three years of working experience in both private and public sectors in Ethiopia. She was the China Liaison Officer for project ‘Partnership for Investment and Growth in Africa’ at International Trade Centre, where she accumulated rich experience in investment and trade promotion


Founder and CEO

Hannah Ryder is the Founder & CEO of Development Reimagined. A former diplomat and economist with 20 years of experience, named one of 100 most influential Africans in 2021, she is also Senior Associate for the Africa Program of the Center for Strategic International Studies (CSIS), sits on the Board of the Environmental Defence Fund, and is a member of UAE's International Advisory Council on the New Economy. Prior to her role at DR, Ms Ryder led the United Nations Development Programme (UNDP)’s work with China to help it scale up and improve its cooperation with other developing countries, including in Africa. She has also played various advisory roles for the UN and OECD and co-authored the seminal Stern Review of the Economics of Climate Change in 2006.